News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Friday, February 27, 2026The EU Parliament has advanced the Critical Medicines Act aimed at strengthening Europes pharmaceutical supply chain security starting in
Neurogene announces FDA Breakthrough Therapy designation for NGN-401 in Rett syndrome
Friday, February 27, 2026Neurogene Inc has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to NGN its investigational gene therapy for Rett syndrome
FDA Accepts Viatris Supplemental Application for MR-141 in Presbyopia
Thursday, February 26, 2026Viatris Inc has announced that the US Food and Drug Administration has accepted for review its supplemental New Drug Application for MR phentolamine ophthalmic solution for the treatment of presbyopia The application has been assigned a PDUFA target...
Frontier Biotech and GSK Sign Global Exclusive Licensing Agreement for siRNA Therapies
Thursday, February 26, 2026Frontier Biotechnologies Inc has entered into a global exclusive licensing agreement with GSK for two of its small interfering RNA siRNA pipeline products
Sanofi Gains European Commission Approval for Sarclisa in Combination with VRd for Newly Diagnosed Multiple Myeloma Patients
Wednesday, February 25, 2026The European Commission has approved Sanofis Sarclisa in combination with bortezomib lenalidomide and dexamethasone VRd for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant
Sandoz Ranluspec Biosimilar to Lucentis Approved by European Commission
Tuesday, February 24, 2026The European Commission has approved Ranluspec Sandoz and Lupins biosimilar to Genentechs Lucentis ranibizumab marking a key advancement for ophthalmic treatments in Europe
Vanda Pharmaceuticals Receives FDA Approval for BYSANTI™ (milsaperidone) for Bipolar I Disorder and Schizophrenia
Tuesday, February 24, 2026Vanda Pharmaceuticals Inc Nasdaq VNDA has received approval from the US Food and Drug Administration FDA for BYSANTI milsaperidone tablets The medication is approved for the acute treatment
Angelini Pharma and Quiver Bioscience Form Strategic Collaboration to Develop Therapies for Genetic Epilepsies
Tuesday, February 24, 2026Angelini Pharma part of the privately owned Angelini Industries and Quiver Bioscience a company focused on discovering therapies for central nervous system CNS disorders have entered a collaboration and licensing
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security
Friday, February 20, 2026The European Parliament has adopted its position on the Critical Medicines Act paving the way for negotiations to strengthen Europes medicine supply chain resilience
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
Friday, February 20, 2026Roche has announced that the US Food and Drug Administration has accepted its New Drug Application NDA for giredestrant The investigational oral therapy is being reviewed in combination with everolimus
